BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Savara Reports Second Quarter 2019 Financial Results and Provides Business Update

  Savara Inc. reported financial results for the second quarter ending June 30, 2019 and provided a business update.

  August 8, 2019

   · 

  8 min read
• Business

  Omeros Corporation Reports Second Quarter 2019 Financial Results

  Omeros Corporation announced recent highlights and developments as well as financial results for the second quarter ended June 30, 2019.

  August 8, 2019

   · 

  12 min read
• Business

  Accelerate Diagnostics Names Jack Phillips Chief Operating Officer

  Mr. Phillips joins Accelerate from Roche Diagnostics, the world’s leading diagnostics company.

  August 8, 2019

   · 

  3 min read
• Business

  Nevro Reports Second Quarter 2019 Financial Results

  Revenue for the second quarter of 2019 was $93.6 million, a 3% decrease compared to $96.1 million during the prior year period.

  August 8, 2019

   · 

  7 min read
• Business

  Quidel Reports Second Quarter 2019 Financial Results

  Financial results for the second quarter ended June 30, 2019.

  August 8, 2019

   · 

  21 min read
• Biotech Bay

  Women can reduce exposure to opioids after cesarean delivery

  Eating and moving sooner after surgery can improve the recovery experience for new moms

  August 8, 2019

   · 

  5 min read
• Business

  Synlogic to Present at the 2019 Wedbush PacGrow Healthcare Conference

  An archived copy of the webcast will be available on the Synlogic website for approximately 30 days after the event.

  August 8, 2019

   · 

  1 min read
• Business

  Biohaven Pharmaceuticals Reports Second Quarter 2019 Financial Results and Recent Business Developments

  Submitted Two New Drug Applications to FDA for Zydis® Orally Dissolving Tablet and tablet formulations of rimegepant in the second quarter of 2019

  August 8, 2019

   · 

  20 min read
• Business

  MiMedx Announces Agreement Regarding 2019 and 2020 Shareholder Meetings

  The agreement provides that MiMedx will work in good faith to endeavor to complete the Restatement by December 16, 2019.

  August 8, 2019

   · 

  2 min read
• Business

  Scientific Learning Reports Second Quarter 2019 Financial Results

  Unaudited financial results for the period ending June 30, 2019.

  August 8, 2019

   · 

  3 min read